Drug Discovery has been one of the areas where piece-meal Services have been outsourced by both Pharma and Biotech companies for over 10 years now,in the Asian region.Even as a number of companies have successfully scaled these operations,as a Services business,and have delivered high-quality services at a very competitive cost to Pharmacos and Biotechs,a few organizations have focused on integrated Drug Discovery offerings on Research Funding and Shared-risk business models.